Pre|Transplant Azacitidine and Allogeneic Hematopoietic Cell ...

Pre-Transplant Therapy with Azacitidine Versus Induction ...

While allogeneic hematopoietic cell transplantation (HCT) has proven curative potential for myelodysplastic syndrome (MDS), relapse after HCT remains a ...

Low-Dose Azacitidine After Allogeneic Stem Cell Transplantation for ...

The authors hypothesized that low doses of the hypomethylating agent 5-azacitidine may maximize the graft-versus-leukemia effect and may be tolerated well ...

New drugs before, during, and after hematopoietic stem cell ...

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous ...

Prophylactic or Preemptive Low-Dose Azacitidine and Donor ...

8. Appelbaum, FR. Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Best Pract Res Clin ...

Prospective phase II study of prophylactic low-dose azacitidine and ...

Although allogeneic hematopoietic stem cell transplantation (HSCT) is presently the only curative option for many patients with acute myeloid ...

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation ...

The aim of this study was to assess the impact of treatment prior to transplantation with AZA on survival, relapse, and nonrelapse mortality (NRM).

Azacitidine maintenance after allogeneic hematopoietic cell ...

Allogeneic hematopoietic cell transplantation (alloHCT) is standard-of-care therapy for patients with myelodysplastic syndrome (MDS) and acute ...

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation ...

Role of Post-Allogeneic Hematopoietic Stem Cell Transplantation Low-Dose Azacitidine for Prevention of Relapse in Patients with Acute Myeloid Leukemia and ...

Azacitidine maintenance therapy post-allogeneic stem cell ...

Allogeneic hematopoietic stem cell transplant (HSCT) is the potential curative modality for poor-risk acute myeloid leukemia (AML), ...

5-Azacitidine for myelodysplasia before allogeneic hematopoietic ...

Relapse remains a leading cause for treatment failure after hematopoietic cell transplantation (HCT) in patients with intermediate- or ...

Feasibility of allogeneic stem-cell transplantation after azacitidine ...

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

A phase 3 randomized study of 5-azacitidine maintenance vs ...

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for patients with myelodysplastic syndromes (MDS) ...

Azacitidine and lenalidomide combination: a novel relapse ...

IntroductionWhile allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a curative regimen for acute myeloid leukemia (AML), relapse of AML ...

Comparison Between 5-Azacytidine Treatment and Allogeneic Stem ...

PURPOSEIn contrast to 5-azacytidine (5-aza), allogeneic stem-cell transplantation (HSCT) represents a curative treatment strategy for patients with ...

Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic ...

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is rarely recommended for unfit patients with newly diagnosed acute myeloid leukemia ...

Subcutaneous low-dose azacitidine as maintenance therapy ...

Ryan, et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid ...

Allogeneic hematopoietic cell transplantation for acute myeloid ...

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter ...

Azacitidine Maintenance Following Allogeneic Hematopoietic Stem ...

1Hematology and Stem Cell Transplant, James Cancer Hospital and Solove Research Institute, Ohio State University, Columbus, OH 2Internal ...

Pre-Transplant 5-Azacitidine In Patients With High-Risk ...

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant.

Maintenance therapy with low‐dose azacitidine after allogeneic ...

Shpall, MD (Department of Stem Cell Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Tex), Muzaffar Qazilbash, MD ...